Europe Diagnostic Imaging Market By Type (X-Ray Imaging Solutions, Ultrasound Systems, MRI Systems, CT Scanners, Nuclear Imaging Solutions, Mammography, Others), By Mobility (Portable v/s Standalone), By Source (Domestic Vs Import), By Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, Others), By End Users (Hospitals & Clinics, Diagnostic Centers, Ambulatory Care Centers, Others), By Country, Competition, Forecast & Opportunities, 2020-2030F

Market Overview

Europe Diagnostic Imaging Market was valued at USD 12.32 Billion in 2024 and is expected to reach USD 16.79 Billion by 2030, growing with a CAGR of 5.25% in the forecast period. The Europe diagnostic imaging market is witnessing steady growth, driven by rising healthcare awareness, increasing demand for early disease detection, and the adoption of advanced imaging technologies. With healthcare systems across Europe placing a stronger emphasis on preventive care and precision diagnostics, the market for imaging modalities such as MRI, CT, ultrasound, X-ray, and nuclear imaging is expanding significantly. The growing geriatric population and rising incidence of chronic diseases such as cancer, cardiovascular conditions, and neurological disorders are further propelling demand.

One of the key trends shaping the European diagnostic imaging market is the integration of artificial intelligence (AI) and machine learning (ML) into imaging systems. These technologies are improving image interpretation accuracy, optimizing workflow efficiencies, and reducing diagnosis time. Several countries in Western Europe, including Germany, the UK, and France, are leading in AI-driven imaging adoption, supported by strong regulatory frameworks and well-developed healthcare infrastructure.

Public and private investments in diagnostic infrastructure, coupled with favorable reimbursement policies in many European countries, are accelerating the uptake of imaging systems. Governments are also focusing on upgrading imaging equipment in public hospitals to improve diagnostic capabilities in underserved and rural areas. This, combined with the growth of teleradiology services, is enhancing access to quality diagnostic services across the continent. However, market growth is moderated by factors such as high capital investment requirements, stringent regulatory compliance, and a shortage of skilled radiologists in certain regions. In addition, economic disparities across Eastern and Western Europe create varying levels of access and adoption of advanced diagnostic imaging technologies. Despite these challenges, the outlook for the Europe diagnostic imaging market remains positive. Market players are investing in product innovation, such as low-dose imaging systems and portable modalities, to cater to evolving clinical needs. Strategic partnerships and mergers are also being pursued to expand geographic reach and strengthen service offerings.

Key Market Drivers

Ageing Population and Rise in Chronic Diseases is Driving Europe Diagnostic imaging Market

The Europe diagnostic imaging market is witnessing sustained growth, propelled by a significant demographic shift and the escalating burden of chronic diseases. As the region’s population continues to age, demand for advanced diagnostic tools has surged, positioning imaging technologies such as MRI, CT, and ultrasound at the forefront of healthcare delivery.

Europe is experiencing a demographic transformation, with a substantial portion of its population entering the 65+ age group. According to Eurostat, nearly 21.6% of the EU population was aged 65 years or older in 2023 . This shift is contributing to increased utilization of diagnostic imaging, as older adults are more susceptible to age-related conditions such as cardiovascular diseases, osteoarthritis, and neurodegenerative disorders. The early detection and ongoing monitoring of these conditions rely heavily on imaging modalities, thereby strengthening their role in geriatric care. According to Eurostat, in 2023, over one-third (35.0%) of individuals in the European Union reported living with a long-standing (chronic) health condition.

In parallel with the ageing population, Europe is grappling with a rising incidence of chronic diseases, including cancer, diabetes, and respiratory illnesses. The World Health Organization (WHO) reports that non-communicable diseases account for nearly 90% of all deaths in the European region. Diagnostic imaging plays a pivotal role across the care continuum—from early diagnosis and treatment planning to disease monitoring and prognosis evaluation. For example, the rising cancer burden has driven increased adoption of advanced imaging technologies such as PET-CT and contrast-enhanced MRI for tumor detection, staging, and response assessment. Similarly, cardiovascular imaging using echocardiography and cardiac CT is critical for managing ischemic heart disease and heart failure, both of which are prevalent in ageing populations.

Europe’s robust healthcare infrastructure and ongoing investments in medical technology are also reinforcing the growth trajectory of the diagnostic imaging market. Vendors are increasingly focused on integrating artificial intelligence (AI), 3D imaging, and image-guided interventions to enhance diagnostic accuracy and workflow efficiency. Furthermore, public health initiatives and reimbursement policies across major economies such as Germany, France, and the UK continue to support the widespread adoption of imaging services.

The convergence of an ageing demographic and chronic disease prevalence presents both opportunities and challenges for market participants. Diagnostic imaging companies must align their product development and service delivery strategies to cater to the evolving clinical demands. Investment in portable and point-of-care imaging systems, particularly for use in home care and outpatient settings, is gaining traction. Moreover, collaboration between technology providers, healthcare institutions, and policymakers will be essential in addressing rising imaging volumes while ensuring cost-effectiveness and equitable access across the region.

Increasing Focus on Early and Preventive Diagnosis

In recent years, Europe has witnessed a fundamental shift in healthcare priorities—from reactive treatment to proactive, preventive care. At the heart of this transformation is the growing reliance on early and preventive diagnosis, which is emerging as a key driver of the diagnostic imaging market across Europe. As healthcare systems aim to reduce long-term treatment costs and improve clinical outcomes, the role of imaging technologies in facilitating timely disease detection is becoming increasingly critical. European governments and health agencies are placing greater emphasis on preventive healthcare to mitigate the rising burden of non-communicable diseases such as cancer, cardiovascular conditions, and neurodegenerative disorders. Early diagnosis not only enables effective disease management but also significantly reduces healthcare expenditure by limiting the need for advanced-stage treatments. This strategic pivot has led to increased investments in diagnostic imaging infrastructure, particularly for modalities that support early detection—such as MRI, CT scans, PET, mammography, and ultrasound. Imaging technologies are being widely integrated into national screening programs, enhancing diagnostic reach and enabling physicians to make timely, evidence-based decisions.

Public health policies and EU-wide initiatives are reinforcing the importance of early diagnostics. The EU’s Beating Cancer Plan, for example, promotes widespread cancer screening and emphasizes the deployment of next-generation imaging tools. As per Eurostat, In 2022, over half the people (within the age range of screening programmes) in Belgium, Denmark, Estonia, the Netherlands, Slovenia, Finland and Sweden had been screened for colorectal cancer within the previous 2 years. Likewise, recovery funding from the EU4Health programme is being used to upgrade diagnostic capabilities across member states, especially in underserved areas. Governments are also actively promoting population-wide screening programs for breast, lung, and colorectal cancers—conditions where early-stage identification through imaging significantly improves survival rates. These initiatives are contributing to a steady rise in imaging procedures across Europe. Europe's aging population is a major contributor to the increased focus on early diagnosis. As individuals age, their risk of developing chronic illnesses rises, necessitating routine screening and imaging-based monitoring. Preventive imaging is also gaining traction among younger populations with lifestyle-related risk factors such as obesity, hypertension, and diabetes. As a result, healthcare providers are increasingly relying on imaging not only for diagnosis but also for screening asymptomatic individuals, detecting diseases before clinical symptoms appear.

Technological advancements are amplifying the impact of preventive diagnostics. Artificial intelligence and machine learning are improving the speed, accuracy, and predictive capability of diagnostic imaging. Automated detection of early signs of disease in radiological scans, for instance, allows clinicians to act swiftly, often before a condition becomes critical. Portable imaging devices and mobile diagnostic vans are also being deployed in rural and remote regions, making early diagnosis more accessible and reducing disparities in healthcare delivery. The increasing focus on early and preventive diagnosis is reshaping the landscape of the European diagnostic imaging market. As healthcare shifts from intervention to prevention and prediction, imaging will remain a central pillar of this evolution. Market players that align with this preventive paradigm—through innovation, accessibility, and strategic partnerships—will be well-positioned to lead in the years ahead.

Download Free Sample Report

Key Market Challenges

Budgetary Constraints in Public Healthcare Systems

Many European countries operate under tight public healthcare budgets, which directly impacts capital investments in advanced diagnostic imaging equipment such as MRI, CT, and PET scanners. High initial costs, coupled with long procurement cycles and limited reimbursement for imaging procedures, act as barriers to adoption. Consequently, hospitals often rely on outdated equipment, leading to inefficiencies in diagnosis and patient care.

Key Market Trends

Technological Advancements and Innovation

The Europe diagnostic imaging market is witnessing significant momentum, fueled by continuous technological advancements in imaging modalities. As healthcare systems across the region strive for precision, efficiency, and early disease detection, the adoption of advanced imaging technologies is transforming diagnostic pathways and improving patient outcomes. This technological evolution is a critical driver for market expansion, supported by favorable regulatory frameworks, aging demographics, and growing investment in healthcare infrastructure.

One of the most notable trends reshaping the market is the integration of artificial intelligence (AI) and machine learning (ML) algorithms into diagnostic imaging. These technologies enable faster image acquisition, automated analysis, and enhanced diagnostic precision—particularly in modalities such as MRI, CT, and mammography. AI-driven tools are proving instrumental in detecting anomalies at earlier stages and reducing inter-observer variability, thereby enhancing clinical decision-making and workflow efficiency.

Leading European healthcare institutions are actively incorporating AI-based imaging platforms, with pilot projects transitioning into full-scale implementations. This digital transformation is not only improving diagnostic throughput but also alleviating the workload on radiologists, a profession currently facing staffing challenges across Europe. Hybrid imaging technologies such as PET/CT, SPECT/CT, and PET/MRI are gaining widespread adoption due to their ability to combine anatomical and functional information in a single scan. These integrated systems provide a comprehensive view of pathological conditions—especially in oncology, cardiology, and neurology—thereby improving disease staging, treatment planning, and monitoring. European countries, particularly Germany, France, and the UK, are investing heavily in hybrid imaging infrastructure to support precision medicine initiatives. Government-backed programs and collaborations between academic institutions and private enterprises are accelerating the deployment of these technologies.

Another key advancement is the development of portable and point-of-care (POC) imaging devices. These systems are revolutionizing diagnostic imaging by enabling real-time, bedside diagnostics, especially in emergency care, critical care, and rural settings. Ultrasound systems, in particular, are becoming more compact, affordable, and user-friendly, leading to their rapid adoption across various clinical environments. The COVID-19 pandemic further underscored the importance of mobile imaging solutions, driving demand for portable X-ray and lung ultrasound devices. This shift is likely to continue, with European manufacturers focusing on lightweight, AI-enabled POC imaging systems that support telemedicine and remote diagnostics.

Advancements in three-dimensional (3D) and four-dimensional (4D) imaging are enhancing diagnostic accuracy and clinical confidence. These modalities offer detailed visualization of anatomical structures and real-time monitoring of dynamic physiological processes. In particular, 4D imaging is gaining traction in fetal medicine, cardiovascular diagnostics, and surgical planning. Manufacturers are investing in next-generation software and image reconstruction techniques to deliver high-resolution 3D/4D images with reduced radiation exposure and shorter scan times. Such innovations are aligning well with Europe's stringent patient safety standards and growing emphasis on minimally invasive diagnostics.

Segmental Insights

Route of Administration Insights

Based on the category of type, the Ultrasound Systems category had the highest share of revenue in 2024. Ultrasound systems are extensively used across various medical disciplines, including obstetrics and gynecology, cardiology, urology, musculoskeletal imaging, and emergency medicine. This versatility significantly contributed to their dominance in the European market. In particular, the rising incidence of chronic conditions such as cardiovascular diseases, liver disorders, and gynecological conditions has increased the demand for real-time, non-invasive diagnostic tools. Ultrasound fits this need well, being a safe, fast, and effective imaging technique without the risks associated with ionizing radiation. Compared to other imaging modalities like MRI and CT, ultrasound systems are significantly more affordable both in terms of initial investment and operating costs. This economic advantage makes them highly attractive for hospitals, diagnostic centers, and even mobile clinics, especially in budget-constrained healthcare systems that are prevalent in parts of Eastern and Southern Europe. Additionally, the advent of portable and handheld ultrasound devices has expanded access to imaging in rural and underserved areas, further driving market penetration.

Mobility Insights

Based on the category of Mobility, the Standalone category secured the largest share of revenue in 2024. Standalone diagnostic imaging centers are often equipped with high-end imaging modalities such as MRI, CT, and PET-CT scanners. These facilities typically function as independent imaging hubs or specialized centers affiliated with hospitals or outpatient clinics. In Europe, where healthcare systems are increasingly adopting decentralized diagnostic services, standalone centers play a vital role in managing high patient volumes efficiently. Their focused setup allows them to cater to a broader demographic across both public and private healthcare networks, thereby generating significant revenue. One of the key strengths of standalone diagnostic centers lies in their streamlined workflows. These centers are purpose-built for imaging procedures, which minimizes bottlenecks and reduces waiting times. Unlike mobile units or integrated systems within hospitals, standalone centers often enjoy greater autonomy in scheduling, operations, and staffing, allowing them to deliver quicker turnaround times for diagnostic results. This efficiency contributes to higher throughput and, consequently, greater revenue generation.

Download Free Sample Report

Regional Insights

In 2024, Germany held the largest market share in terms of revenue. Germany's ageing population—and rising chronic and oncological disease rates—drive consistent imaging demand. Germany is currently among the five "super-aged" societies globally, with individuals aged 65 and above comprising a significant portion of its population. This demographic segment is expected to expand further, projected to account for nearly one-third of the country's total population by 2050. The predictable volume supports robust imaging equipment turnover, while early cancer screening initiatives and teleradiology expansion further sustain the market. German providers are early adopters of cutting-edge modalities like photon-counting CT and hybrid imaging (e.g., PET‑CT, PET‑MRI), complemented by AI‑driven reconstruction and dose‑optimization features. Siemens Healthineers, headquartered in Erlangen, has been at the forefront, pioneering photon‑counting CT scanners like the Naeotom Alpha and hybrid systems since the early 2000s

Recent Developments

• In June 2025, Bracco Imaging S.p.A., a global leader in diagnostic imaging, and Subtle Medical, Inc., a front-runner in AI-driven image acquisition technologies, announced that AiMIFY—their jointly developed, AI-powered software for brain magnetic resonance imaging (MRI)—has received CE (Conformité Européenne) Mark certification under the European Medical Device Regulation (MDR). This regulatory achievement affirms that AiMIFY™ meets the European Union’s stringent standards for safety, health, and environmental protection.
• In June 2025, United Imaging, a global leader in advanced diagnostic imaging and radiotherapy solutions, announced the launch of two innovative additions to its product portfolio — the uMI Panvivo and the uMR Ultra. Recently CE-marked, both systems are poised to set new benchmarks for precision and performance in medical imaging.
• In February 2025, Royal Philips announced that its Radiology Operations Command Center Console has been certified under the EU Medical Device Regulation (MDR) for its remote scanning capabilities. This certification marks a significant advancement in expanding access to radiology expertise across Europe. The solution enables expert radiologists to support technologists in real time by remotely controlling imaging procedures, thereby ensuring the acquisition of high-quality diagnostic images and enhancing both clinical confidence and patient outcomes.
• In February 2024, Fujifilm Healthcare Europe introduced its latest 1.5 Tesla superconductive MRI system, the Echelon Synergy, during the European Congress of Radiology 2024. This advanced system incorporates AI-powered deep learning technology to significantly enhance image clarity and accelerate scanning times.
• In May 2023, GE HealthCare secured a USD 30 million order from St. Luke's University Health Network for the deployment of over 20 AI-enabled computed tomography (CT) systems. Delivered through a Smart Subscription model, the initiative ensures seamless integration into the existing network infrastructure, along with regular AI and software updates.
• In February 2022, FUJIFILM VisualSonics entered into a strategic partnership with PIUR IMAGING to integrate Ultra High Frequency 3D ultrasound imaging into the Vevo MD platform. This collaboration aims to advance clinical research across various specialties, including vascular, dermatological, and neurological applications.

Key Market Players

• Siemens Healthineers AG
• GE Healthcare Europe, GmbH
• Koninklijke Philips N.V.
• Agfa-Gevaert N.V.
• Esaote S.p.A
• Planmed Oy
• Carl Zeiss AG
• Accenture UK Medical Imaging Solutions
• FUJIFILM Europe GmbH
• Hologic Europe

Report Scope:

In this report, the Europe Diagnostic imaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Europe Diagnostic imaging Market, By Type:

o   X-Ray Imaging Solutions

o   Ultrasound Systems

o   MRI Systems

o   CT Scanners

o   Nuclear Imaging Solutions

o   Mammography

o   Others

• Europe Diagnostic imaging Market, By Mobility:

o   Portable

o   Standalone

• Europe Diagnostic imaging Market, By Source:

o   Domestic

o   Import

• Europe Diagnostic imaging Market, By Application:

o   Cardiology

o   Oncology

o   Neurology

o   Orthopedics

o   Gastroenterology

o   Gynecology

o   Others

• Europe Diagnostic imaging Market, By End User:

o   Hospitals & Clinics

o   Diagnostic Centers

o   Ambulatory Care Centers

o   Others

• Europe Diagnostic imaging Market, By Country:

o   Germany

o   France

o   United Kingdom

o   Italy

o   Spain

o   Switzerland

o   Netherlands

o   Turkey

o   Sweden

o   Belgium

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Europe Diagnostic imaging Market.

Available Customizations:

Europe Diagnostic imaging market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Europe Diagnostic imaging Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]